Tenaya Therapeutics Inc (TNYA) At $0.87: It’s Worth Your Interest

Tenaya Therapeutics Inc (NASDAQ:TNYA) concluded the trading at $0.87 on Thursday, June 04 with a rise of 20.17% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $0.72 and 5Y monthly beta was reading 2.915 with its price kept floating in the range of $0.734 and $0.87 on the day. Considering stock’s 52-week price range provides that TNYA hit a high price of $4.06 and saw its price falling to a low level of $0.36 during that period. Over a period of past 1-month, stock came adding 39.18% in its value.

With its current market valuation of $140.88 million, Tenaya Therapeutics Inc is set to declare its quarterly results on 2025-May-07. Analysts are in estimates of -0.18 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -0.78 for current year with estimates of that growing to -0.63 in next year.

According to ratings assigned by 3 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending Tenaya Therapeutics Inc (TNYA) as a Hold, while 3 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.

Digging deeper we become aware of the PEG ratio of the TNYA stock which is currently positioned at 0. It further provides that stock’s current price level is 32.69% away from its 20-day simple moving average and is 54.53% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 74.76 while volatility remained at 10.32% over the past week which changes to 9.22% when measuring it over the past month. Beta is valued at 3.01.

Having a second look at Tenaya Therapeutics Inc (NASDAQ:TNYA) provides that stock’s average daily trading volume for 3 months was 2.38 million, while it jumped to 1756500 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 162.66 million.

The percentage of outstanding shares held by the insiders is 17.51% while it is 27.53% for the institutional holders. The figures also indicate that as of 2025-06-13, number of stock’s short shares was 11.89 million which implies a short ratio of 4.56. This shows down a 2013.00 of Short Interest in company’s outstanding shares on the day. In June the standing of shares short improved as it was 12.16 million in the previous month. Subtraction of -75.39% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.